AKT1 and apocrine adenocarcinoma: At the molecular level, apocrine carcinomas frequently harbor mutations in PIK3CA, PTEN, AKT, or TP53, whereas alterations in the MAPK pathway genes (KRAS, NRAS, BRAF) are less common.